Short-term hyperprolactinemia decreases allergic inflammatory response of the lungs
2015
Ochoa-Amaya, Julieta E. | Hamasato, Eduardo K. | Tobaruela, Carla N. | Queiroz-Hazarbassanov, Nicolle | Anselmo Franci, Janete A. | Palermo Neto, João | Greiffo, Flavia R. | de Britto, Auriléia Aparecida | Vieira, Rodolfo Paula | Ligeiro de Oliveira, Ana P. | Massoco, Cristina de O. | Felicio, Luciano F.
Prolactin is a major immunomodulator. The present study evaluated the effects of short-term hyperprolactinemia induced by domperidone before ovalbumin antigenic challenge on the lung's allergic inflammatory response.To induce hyperprolactinemia, domperidone was injected in rats at a dose of 5.1mg·kg⁻¹ per day, i.p., for 5days from 10th to 14th day after OVA immunization. Total and differential leukocyte counts from bronchoalveolar lavage (BAL), femoral marrow lavage (FML), and blood were analyzed. The percentages of mucus and collagen production were evaluated. Levels of corticosterone and prolactin in serum, interleukin-4 (IL-4), IL-6, IL-10, tumor necrosis factor α (TNF-α) in lung explants supernatants were measured and interferon gamma (IFN-γ) in bronchiolar lavage cells suspensions (BAL) was measured.The rats that were subjected to short-term hyperprolactinemia exhibited a decrease in leukocyte counts in bronchoalveolar lavage, cellularity decrease in femoral marrow lavage fluid, a lower percentage of mucus, and an increase in lung IL-4, IL-6, IL-10, TNF-α and IFN-γ expression.Hyperprolactinemia induced before antigenic challenge decreased allergic lung inflammation. These data suggest that prolactin may play a role in the pathophysiology of asthma. The present study demonstrates a prospective beneficial side effect of domperidone for asthmatic patients.
Afficher plus [+] Moins [-]Mots clés AGROVOC
Informations bibliographiques
Cette notice bibliographique a été fournie par National Agricultural Library
Découvrez la collection de ce fournisseur de données dans AGRIS